McBride plc (LON:MCB – Get Free Report) shot up 13.8% on Friday . The stock traded as high as GBX 120 ($1.46) and last traded at GBX 115.50 ($1.41). 1,784,547 shares were traded during mid-day trading, an increase of 487% from the average session volume of 304,262 shares. The stock had previously closed at GBX 101.50 ($1.23).
McBride Price Performance
The company has a debt-to-equity ratio of 222.08, a current ratio of 0.92 and a quick ratio of 0.54. The stock has a market capitalization of £216.04 million, a price-to-earnings ratio of 655.26, a price-to-earnings-growth ratio of -0.36 and a beta of 1.17. The stock has a 50 day moving average price of GBX 106.30 and a 200-day moving average price of GBX 117.65.
Insider Buying and Selling at McBride
In other McBride news, insider Christopher Ian Charles Smith sold 145,000 shares of the stock in a transaction dated Monday, November 4th. The shares were sold at an average price of GBX 112 ($1.36), for a total value of £162,400 ($197,590.95). Also, insider Mark Strickland bought 9,500 shares of the stock in a transaction dated Friday, November 15th. The shares were bought at an average price of GBX 97 ($1.18) per share, for a total transaction of £9,215 ($11,211.83). 5.78% of the stock is currently owned by insiders.
McBride Company Profile
McBride plc, together with its subsidiaries, manufactures and sells private label household and personal care products to retailers and brand owners in the United Kingdom, Germany, France, Australia, rest of Europe, rest of Asia-Pacific, and internationally. The company operates through five segments: Liquids, Powders, Unit dosing, Aerosols, and Asia Pacific.
Read More
- Five stocks we like better than McBride
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for McBride Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McBride and related companies with MarketBeat.com's FREE daily email newsletter.